309 related articles for article (PubMed ID: 33087888)
21. Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort.
Li H; LaDuca H; Pesaran T; Chao EC; Dolinsky JS; Parsons M; Spurdle AB; Polley EC; Shimelis H; Hart SN; Hu C; Couch FJ; Goldgar DE
Genet Med; 2020 Apr; 22(4):701-708. PubMed ID: 31853058
[TBL] [Abstract][Full Text] [Related]
22. BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
Lindor NM; Goldgar DE; Tavtigian SV; Plon SE; Couch FJ
Oncologist; 2013; 18(5):518-24. PubMed ID: 23615697
[TBL] [Abstract][Full Text] [Related]
23. MARGINAL: An Automatic Classification of Variants in
Karalidou V; Kalfakakou D; Papathanasiou A; Fostira F; Matsopoulos GK
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358902
[TBL] [Abstract][Full Text] [Related]
24. Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
Billaud A; Chevalier LM; Augereau P; Frenel JS; Passot C; Campone M; Morel A
Genome Med; 2021 Nov; 13(1):174. PubMed ID: 34749799
[TBL] [Abstract][Full Text] [Related]
25. A new bioinformatics tool to help assess the significance of BRCA1 variants.
Cusin I; Teixeira D; Zahn-Zabal M; Rech de Laval V; Gleizes A; Viassolo V; Chappuis PO; Hutter P; Bairoch A; Gaudet P
Hum Genomics; 2018 Jul; 12(1):36. PubMed ID: 29996917
[TBL] [Abstract][Full Text] [Related]
26. Determination of Pathogenicity of
Brown A; Zamanpoor M; Love DR; Prosser DO
Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e324-e334. PubMed ID: 31897316
[TBL] [Abstract][Full Text] [Related]
27. BRCA1/2 missense mutations and the value of in-silico analyses.
Sadowski CE; Kohlstedt D; Meisel C; Keller K; Becker K; Mackenroth L; Rump A; Schröck E; Wimberger P; Kast K
Eur J Med Genet; 2017 Nov; 60(11):572-577. PubMed ID: 28807866
[TBL] [Abstract][Full Text] [Related]
28.
Khandakji M; Habish HHA; Abdulla NBS; Kusasi SAA; Abdou NMG; Al-Mulla HMMA; Al Sulaiman RJAA; Bu Jassoum SM; Mifsud B
Physiol Genomics; 2023 Aug; 55(8):315-323. PubMed ID: 37335020
[TBL] [Abstract][Full Text] [Related]
29. Variant classification changes over time in BRCA1 and BRCA2.
Mighton C; Charames GS; Wang M; Zakoor KR; Wong A; Shickh S; Watkins N; Lebo MS; Bombard Y; Lerner-Ellis J
Genet Med; 2019 Oct; 21(10):2248-2254. PubMed ID: 30971832
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions.
Clark KA; Paquette A; Tao K; Bell R; Boyle JL; Rosenthal J; Snow AK; Stark AW; Thompson BA; Unger J; Gertz J; Varley KE; Boucher KM; Goldgar DE; Foulkes WD; Thomas A; Tavtigian SV
Am J Hum Genet; 2022 Jun; 109(6):1153-1174. PubMed ID: 35659930
[TBL] [Abstract][Full Text] [Related]
31. BRCA1 and BRCA2 truncating mutations and variants of unknown significance in Egyptian female breast cancer patients.
AbdelHamid SG; Zekri AN; AbdelAziz HM; El-Mesallamy HO
Clin Chim Acta; 2021 Jan; 512():66-73. PubMed ID: 33278427
[TBL] [Abstract][Full Text] [Related]
32. Changes in classification of genetic variants in BRCA1 and BRCA2.
Kast K; Wimberger P; Arnold N
Arch Gynecol Obstet; 2018 Feb; 297(2):279-280. PubMed ID: 29302806
[TBL] [Abstract][Full Text] [Related]
33. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
35. Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling.
Moghadasi S; Hofland N; Wouts JN; Hogervorst FB; Wijnen JT; Vreeswijk MP; van Asperen CJ
J Med Genet; 2013 Feb; 50(2):74-9. PubMed ID: 23231788
[TBL] [Abstract][Full Text] [Related]
36. Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.
Jarhelle E; Riise Stensland HM; Mæhle L; Van Ghelue M
Fam Cancer; 2017 Jan; 16(1):1-16. PubMed ID: 27495310
[TBL] [Abstract][Full Text] [Related]
37. Reclassification of
Ha HI; Ryu JS; Shim H; Kong SY; Lim MC
J Gynecol Oncol; 2020 Nov; 31(6):e83. PubMed ID: 33078592
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
Eccles DM; Mitchell G; Monteiro AN; Schmutzler R; Couch FJ; Spurdle AB; Gómez-García EB;
Ann Oncol; 2015 Oct; 26(10):2057-65. PubMed ID: 26153499
[TBL] [Abstract][Full Text] [Related]
39. Functional evaluation of BRCA1/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model.
Guo Q; Ji S; Takeuchi K; Urasaki W; Suzuki A; Iwasaki Y; Saito H; Xu Z; Arai M; Nakamura S; Momozawa Y; Chiba N; Miki Y; Matsuura M; Sunada S
J Hum Genet; 2023 Dec; 68(12):849-857. PubMed ID: 37731132
[TBL] [Abstract][Full Text] [Related]
40. A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function.
Starita LM; Islam MM; Banerjee T; Adamovich AI; Gullingsrud J; Fields S; Shendure J; Parvin JD
Am J Hum Genet; 2018 Oct; 103(4):498-508. PubMed ID: 30219179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
